
    
      The BARD® True™ Flow Valvuloplasty Perfusion Catheter Study is a prospective, single-center,
      non-randomized, single-arm observational study intended to collect data to confirm the
      performance and safety of the BARD® True™ Flow Valvuloplasty Perfusion Catheter (True™ Flow
      catheter) when used for dilatation of the aortic valve in preparation for Transcatheter
      Aortic Valve Implantation (TAVI). This study will be conducted in conformance with the
      Declaration of Helsinki, applicable national privacy laws, and European, national regulations
      and International Organization for Standardization (ISO) requirements (ISO 14155:2011 (E)).
    
  